Partner Lee Rosebush and Associate Marc Wagner delve into what compounding pharmacies can and cannot do under Section 503B of the Federal Food, Drug and Cosmetic Act in an article for the American Health Law Association titled “Dispensing Compounded Drugs from a 503B Outsourcing Facility and the Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug and Cosmetic Act.” Published Oct. 29, 2024, on the association’s website, the article discusses the nuances within the wording of the act, such as “dispensing” versus “selling” a compounded drug.
Copyright 2024, American Health Law Association, Washington, DC. Reprint permission granted.